Indian court upholds Natco's compulsory license for Bayer's Nexavar; Valeant makes FTC filing on proposed Allergan takeover;

@FiercePharma: Top-read on FP Monday: Riled by $84,000 Sovaldi, Senate panel digs into Gilead's Pharmasset buy. Article | Follow @FiercePharma

@EricPFierce: Too bad Pfizer couldn't point to the Cork jobs when it was being savaged over its run at AstraZeneca. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Teva rebel investor Landa's gearing up for a proxy fight--and he can win, he says. Report | Follow @CarlyHFierce

> The High Court in Bombay, India, has upheld a compulsory license for Natco to manufacture a generic of Bayer's cancer drug Nexavar. Story

> Valeant Pharmaceuticals ($VRX) said today that it has filed a premerger notification with the U.S. Federal Trade Commission for its proposed acquisition of Allergan. Announcement

> Janssen will sell Pfizer's antidepressant Efexor XR in South Korea. Story

> GlaxoSmithKline ($GSK) has recalled about 10,600 bottles of its Panadol painkiller in Puerto Rico because the packaging was not found to be child-resistant. Story

> Salix Pharmaceuticals ($SLXP) and Progenics Pharmaceuticals ($PGNX) announced that the FDA has informed them it can approve Relistor subcutaneous injection for the treatment of opioid-induced constipation (OIC) in cancer patients based on the data they have submitted. Report

> Mallinckrodt ($MNK) and Questcor Pharmaceuticals ($QCOR) have set Aug. 14 shareholder meetings to vote on their proposed merger. Release

> Portugal-based Bial and Latin-American focused moksha8 have approved a license for the commercialization of eslicarbazepine acetate in Brazil and Mexico for the treatment of epilepsy. Release

Medical Device News

@FierceMedDev: Abbott continues evolution toward devices, planning to sell generics portfolio for $5.3B. Article | Follow @FierceMedDev

@StacyALawrence: RT @EmilyMFierce: I wrote a piece for about what it's like to have a rare voice disorder. Story | Follow @StacyALawrence

@VarunSaxena2: ICYMI: FDA panel recommends stronger labeling, limiting use of power morcellation--agency may go further. Story | Follow @VarunSaxena2

@MichaelGFierce: Trending on FierceDrugDelivery: , MicroCHIPS develop remote-controlled with on-off delivery. Article | Follow @MichaelGFierce

@EmilyWFierce: Boston Scientific wins CE mark for next-generation drug-coated balloon catheter. Article | Follow @EmilyWFierce

> Novartis and Google team up to develop smart contact lenses. Article

> Abbott CEO: 'I don't feel the pressure to invert.' More

> St. Jude shells out $200M for chronic pain therapy manufacturer NeuroTherm. Report

Biotech News

@FierceBiotech: Targacept's Alzheimer's hopeful misses the mark in Phase II. Report | Follow @FierceBiotech

@DamianFierce: I love how Twitter has long been criticizing the froth in biotech but then Yellen steps in and it's like, Yo. | Follow @DamianFierce

@EmilyMFierce: Here's what reporters--and you--should look for in scientific studies. More from U.S. News | Follow @EmilyMFierce

> La Jolla leaps on NASH fervor thanks to some preclinical success. News

> Why isn't New York City a biotech hub? More

> Novartis plans to test Alzheimer's drugs in patients without symptoms. Story

Biotech Research News

> Genetic variant may protect against Alzheimer's. More

> Scientists reprogram stem cells into blood cells. Story

> Compound prevents blindness, diabetes in rodents. More

> Eli Lilly Alzheimer's study shows combo therapy clears more amyloid in mice. Article

> Vaccine prevents anthrax infection in preclinical tests. Item

Pharma Manufacturing News

> Glenmark to build $100M plant in North America. News

> Purdue moves forward with $59M plant in North Carolina. Item

> GSK investing $25M for Codexis manufacturing technology. Article

> Job-cutting Pfizer saves 100 jobs in U.K. Story

> PhRMA, BIO, GPhA ask court to trash California drug disposal law. Report

And Finally... Sanofi ($SNY) has donated $2.5 million to the Milken Institute School of Public Health at George Washington University in Washington, DC. Announcement

Suggested Articles

Novartis is taking its MBC campaign to Instagram with a newly launched video series as part of the five-year “Make Your Dialogue Count” effort.

FDA researchers uncover more concerns and fears among front-line workers and minority groups about a COVID-19 vaccine.

As COVID-19 vaccines advance, the FDA held an expert hearing Thursday to talk safety, efficacy, distribution plans and vaccine confidence—plus more.